Taxotere and Radiculitis - a phase IV clinical study of FDA data

Summary:

Radiculitis is reported as a side effect among people who take Taxotere (docetaxel), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Zometa, and have Hypercalcaemia.

The phase IV clinical study analyzes which people have Radiculitis when taking Taxotere. It is created by eHealthMe based on reports of 62,318 people who have side effects when taking Taxotere from the FDA, and is updated regularly.

What is Taxotere?

Taxotere has active ingredients of docetaxel. It is often used in breast cancer. eHealthMe is studying from 62,513 Taxotere users. Check the latest studies of Taxotere.

What is Radiculitis?

Radiculitis (inflammation of the spinal nerve roots) is found to be associated with 165 drugs and 198 conditions by eHealthMe. Check the latest studies of Radiculitis.

On Aug, 03, 2026

62,318 people reported to have side effects when taking Taxotere.
Among them, 16 people (0.03%) have Radiculitis.

Among these 16 people:

How long have people been on Taxotere when they have Radiculitis? *

What is the gender of people who have Radiculitis when taking Taxotere? *

female: 87.5 %
male: 12.5 %

What is the age of people who have Radiculitis when taking Taxotere? *

What are other drugs people take besides Taxotere? *

What are other side effects people have besides Radiculitis? *

Oedema Peripheral (superficial swelling): 16 people, 100.00%
Bone Disorder: 16 people, 100.00%
Hypoaesthesia (reduced sense of touch or sensation): 16 people, 100.00%
Osteonecrosis Of Jaw (death of bone of jaw): 16 people, 100.00%
Joint Pain: 16 people, 100.00%
Intervertebral Disc Protrusion (spinal disc protrusion): 15 people, 93.75%
Weakness: 15 people, 93.75%
Spinal Osteoarthritis (joint cartilage loss in spine): 15 people, 93.75%
Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder): 14 people, 87.50%
Injury: 14 people, 87.50%

What are the existing conditions these people have? *

Hypercalcaemia (elevated calcium (ca+) level in the blood): 7 people, 43.75%
Migraine (headache): 6 people, 37.50%
Discomfort: 5 people, 31.25%
Ovarian Cancer (cancer of ovary): 5 people, 31.25%
Neoplasm Malignant (cancer tumour): 5 people, 31.25%
Hot Flush (sudden feelings of heat): 5 people, 31.25%
Granulocyte Count Decreased: 4 people, 25.00%
Metastases To Bone (cancer spreads to bone): 3 people, 18.75%
Pain: 3 people, 18.75%
Insomnia (sleeplessness): 2 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Taxotere and have Radiculitis?

- Check whether Radiculitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Taxotere:

Taxotere (62,513 reports)

Radiculitis treatments and more:

Radiculitis (433 reports)

Browse all side effects of Taxotere:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Radiculitis:

Radiculitis (165 drugs)

Browse all the conditions that are associated with Radiculitis:

Radiculitis (198 conditions)

Related publications that referenced our studies

Byun JS, Kang SH, Lee MJ, Kim SY, Choi HG, Lee HR, "A Case of Scleroderma-like Cutaneous Lesions Induced by Docetaxel in a Patient with Breast Cancer", Journal of Rheumatic Diseases, 2013 Oct .
Byun JS, Kang SH, Lee MJ, Kim SY, Choi HG, Lee HR, "A Case of Scleroderma-like Cutaneous Lesions Induced by Docetaxel in a Patient with Breast Cancer", Journal of Rheumatic Diseases, 2013 Oct .

How the study uses the data?

The study uses data from the FDA. It is based on docetaxel (the active ingredients of Taxotere) and Taxotere (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.